Form 4 for RCEL AVITA Medical, Inc.
Accepted 2024-06-06 00:00:00 ET · period of report 2024-06-05 · accession 0000950170-24-070118 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-06 | 2024-06-05 | RCEL | Crowe Suzanne | Dir | A - Grant | — | +9,200 | 36.4K | +34% | — |
| D | 2024-06-06 | 2024-06-05 | RCEL | Crowe Suzanne | Dir | A - Grant | $0.00 | +3,943 | 3,943 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | A | A | 9,200 | — | 36,426 | D | — | — | (F1) Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date. (F3) Includes 20,560 of the Issuer's CDIs. The Reporting Person's 20,560 CDIs translate into 4,112 of the shares of Common Stock set forth above. (F2) Includes unvested RSUs. |
| 2 | Derivative | Stock Options (Right to Buy) | 2024-06-05 | A | A | 3,943 | $0.00 | 3,943 | D | $9.51 · 2025-06-05 to 2034-06-05 | 1 Common Stock |